GENES, ERBB-2

Clinical trials for GENES, ERBB-2 explained in plain language.

Never miss a new study

Get alerted when new GENES, ERBB-2 trials appear

Sign up with your email to follow new studies for GENES, ERBB-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Early trial tests new combo for Tough-to-Treat breast cancer

Disease control Ongoing

This early-stage study is testing the safety of combining two drugs, H3B-6545 and palbociclib, for women with advanced or metastatic breast cancer that is estrogen receptor-positive and HER2-negative. The main goal is to find the highest dose patients can tolerate without severe …

Matched conditions: GENES, ERBB-2

Phase: PHASE1 • Sponsor: Eisai Inc. • Aim: Disease control

Last updated Apr 02, 2026 05:26 UTC

GENES, ERBB-2

Get alerted when new GENES, ERBB-2 trials appear

Early trial tests new combo for Tough-to-Treat breast cancer